Chair Academic Development Committee
Wednesday, 07 October 2015 12:29
Commencing: December 2015
We are seeking to appoint a new Chair of the Academic Development Committee. The purpose of the role is to enhance the development of academic activity in gastroenterology and liver disease in the UK. The successful candidate would be expected to establish and chair a small committee of influential academics to promote & enhance academic training & careers for medical students, junior doctors, StRs and consultants. The Chair would be expected to represent this committee at the SAC & BSG Training Committee & Education Committee.
Closing date: 31st October 2015
National survey on faecal transplantation for C. difficile
Thursday, 01 October 2015 10:46
We would be grateful if you could kindly spare 2 minutes of your time to participate in this very short national survey exploring your centre's practices for faecal microbiota transplantation (FMT). To date there has been very limited experience of its use the United Kingdom for treating recurrent and refractory Clostridium difficile infection and the reasons for this remain unclear. It is also apparent from published studies that the patient and donor selection criteria, stool characteristics and mode of administration are not standardised and vary from centre to centre. We intend to survey the practices of faecal transplantation for Clostridium difficile infection across the UK and understand barriers involved in setting this up locally. We would really appreciate your help in this. This survey is led by Professor Tariq Iqbal (University Hospital Birmingham), Dr Ailsa Hart (St Marks Hospital), Dr Alaric Colville (Royal Devon and Exeter Hospital), Professor Peter Hawkey (University of Birmingham) and Dr Horace Williams (Imperial College Healthcare Trust). The survey is split into two parts. The first part involves a very short online survey (which closes 31 October); if you agree to take part in the second part of the survey, we would then contact you for 5 minute phone conversation.
M Nabil Quraishi
University Hospital Birmingham
Graham Bull Prize and Goulstonian Lecture 2016
Wednesday, 16 September 2015 13:51
The Graham Bull prize was established in 1988 in honour of Sir Graham Bull, who was the first director of the Clinical Research Centre at Northwick Park. A trust for the Graham Bull Prize was set up to provide money for young research workers under the age of 45 who feel that they have made a major contribution to clinical science. The prize as designed by the trust is specifically for an application and not for nomination of individuals. The work can cover a wide range of expertise, such as molecular and cellular biology, imaging technology, psychiatry, or health sciences. The award is open to RCP members and fellows who must apply for their own work to be considered. The sum of £1,000 is offered on a competitive basis each year.
The winner of this prize will also be invited to deliver the Goulstonian Lecture, an annual lecture endowed in 1635 by Mrs Ellen Goulston in memory of her husband, Dr Theodore Goulston FRCP.
Researchers must be under the age of 45 years on 1 April 2016, and must be a member or fellow of RCP London.
How to apply
Biomedical Catalyst (Round 8) winners announced
Friday, 21 August 2015 14:37
The MRC has announced that 12 new treatments, diagnostics and medical technologies will receive funding from the eighth round of the successful Biomedical Catalyst (BMC) programme jointly run by Innovate UK and the MRC, which contributed £13m of the total £18m in this round.
Two of the 7 MRC-funded projects are in gastroenterology.
Targeted therapy for inflammatory bowel disease
Crohn's disease is a chronic, inflammatory bowel disease, which can cause severe symptoms including abdominal pain, diarrhoea and weight loss, but for which there is currently no cure. Existing therapies are focused on reducing inflammation of the bowel lining and providing temporary relief of symptoms, but researchers at KCL and the NIHR Comprehensive Biomedical Research Centre are searching for a cure. The team are the first in the world to trial a personalised treatment using T cell therapy in patients with the disease with the hope that, if successful, their research could help other debilitating autoimmune disorders.
Spotting bowel cancer sooner with a fluorescent dye
Spraying a fluorescent dye onto the lining of the bowel could help doctors distinguish between normal and cancerous tissue in the bowel. Normal endoscopy to look for bowel cancer can only spot visible, physical changes to the lining of the bowel. Researchers at the University of Oxford will trial the new approach in 50 patients which will coat the bowel in the dye - it will only stick to healthy tissue leaving a 'black spot' where cancerous cells are. They hope that the technique will help spot cancers earlier, when it's more likely that they can be treated successfully.
Page 1 of 5